Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 50.19

+1.8%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (4019)	6/7/2001 3:57:51 PM
From: Jibacoa	Read Replies (2) of 52153

<<Note that this is purely a retrospective analysis. I haven't done any back testing to see if such a pattern of strength is predictive. However it does indicate that something interesting is happening with these stocks.>> Peter: Excuse me for commenting, but it seems that William O'Neel's "Relative Strength Ratio" or the RSI (Relative Strength Index) that shows in several available "charts" serve the purpose of comparing the strength of an individual company vs. "the general market",albeit not necessarily compared to their own sector. Take for instance ASTM, which has shown an increasing RSI both on its daily as well as its weekly charts and today is up 37% on volume already above 5,600,000 I haven't been able to find any specific news to account for it.I don't think the recent news about their new manager for their Zellera division in Germany accounts for all the action. Is anybody on the Thread familiar with the company's research ? Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next